Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

697 public trials 122 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia

NCT00046930

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 92 locations
View Trial Details
Completed

Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes

NCT00003138

Conditions
Anemia, Anemia, Refractory, Bone Marrow Diseases, +3 more
Locations
  • CCOP - Colorado Cancer Research Program, Incorporated Denver, Colorado, United States
  • Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
View all 28 locations
View Trial Details
Completed

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

NCT00045305

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Tufts-NEMC Cancer Center Boston, Massachusetts, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details
Completed

An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)

NCT02775903

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 103 locations
View Trial Details
Completed

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

NCT02743351

Conditions
Acute Graft-versus-host Disease, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +35 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California, San Diego (UCSD) Moores Cancer Center San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
View all 15 locations
View Trial Details

Related conditions